Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Risk factors for hearing impairment among U.S. adults with diabetes: National Health and Nutrition Examination Survey 1999-2004.
Ultraviolet radiation and age at natural menopause in a nationwide, prospective US cohort.
Genetic rescue of functional senescence in synaptic and behavioral plasticity.
Chromosome evolution screens recapitulate tissue-specific tumor aneuploidy patterns.
Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma.
Ward SM, Skinner M, Saha B, Emrick T. Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma. Mol Pharm. 2018 11 05; 15(11):5263-5276.
View in:
PubMed
subject areas
Antineoplastic Agents, Alkylating
Brain Neoplasms
Cell Line, Tumor
Drug Carriers
Drug Compounding
Drug Screening Assays, Antitumor
Glioblastoma
Humans
Methacrylates
Phosphorylcholine
Polymerization
Polymers
authors with profiles
Todd S Emrick PhD
Sarah Ward PhD, ABPP-CN